Drugs / Polyethylene glyco-interferon alfa-2b
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00140725 | Apr 2000 → ? | chronic hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyethylene glyco-interferon alfa-2b | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00140725 ↗ |